PsyBio Therapeutics Corp
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated… Read more
PsyBio Therapeutics Corp (PSYBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.201x
Based on the latest financial reports, PsyBio Therapeutics Corp (PSYBF) has a cash flow conversion efficiency ratio of -0.201x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($339.60K) by net assets ($-1.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PsyBio Therapeutics Corp - Cash Flow Conversion Efficiency Trend (2016–2022)
This chart illustrates how PsyBio Therapeutics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PsyBio Therapeutics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PsyBio Therapeutics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NCR (NIGERIA) PLC
XNSA:NCR
|
N/A |
|
SAFEROADS HLDGS
BE:S4Q
|
N/A |
|
Catalyst Media Group PLC
LSE:CMX
|
-0.002x |
|
LUPA3F
SA:LUPA3F
|
N/A |
|
Lode Gold Resources Inc.
OTCQB:SBMID
|
-0.013x |
|
JAPFA COMFEED -A-
BE:1JC1
|
N/A |
|
CONS
NSE:CONS
|
N/A |
|
ROCA INDUSTRY HOLDINGROCK1 S.A.
RO:ROC1
|
N/A |
Annual Cash Flow Conversion Efficiency for PsyBio Therapeutics Corp (2016–2022)
The table below shows the annual cash flow conversion efficiency of PsyBio Therapeutics Corp from 2016 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-1.59 Million | $-3.44 Million | 2.160x | +184.48% |
| 2021-12-31 | $2.72 Million | $-6.95 Million | -2.557x | -318.17% |
| 2020-12-31 | $-736.91K | $-863.76K | 1.172x | +721.65% |
| 2019-12-31 | $127.99K | $-24.13K | -0.189x | -103.60% |
| 2018-12-31 | $150.25K | $-13.91K | -0.093x | +60.36% |
| 2017-12-31 | $169.97K | $-39.71K | -0.234x | +45.37% |
| 2016-12-31 | $158.53K | $-67.80K | -0.428x | -- |